Status:
COMPLETED
Personal KinetiGraph® Clinical Validation Study
Lead Sponsor:
Global Kinetics Corporation
Conditions:
Movement Disorders
Parkinson Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to clinically validate new measures of the Personal KinetiGraph® (PKG®).
Detailed Description
This is a prospective, observational research study of the Personal KinetiGraph (PKG) System. The PKG System is intended to quantify kinematics of movement disorder symptoms in conditions such as Park...
Eligibility Criteria
Inclusion
- Able and willing to sign a written informed consent for study participation
- Existing diagnosis of a movement disorder or a healthy control subject without diagnosis of a movement disorder
Exclusion
- Bedridden, wheelchair confined, or requires the regular use of an assistive gait device (e.g., walker, cane, etc.)
- Occupation that involves repetitive movement or complete immobility (e.g., janitor, construction, or sedentary with no/limited arm movements such as a taxi driver)
- In the investigator's or sponsor's opinion, subject has any unstable or clinically significant condition that would impair the participant's ability to complete the required PKG watch wear (e.g., subject unable to complete PKG wear instructions per Patient Instruction Manual), complete required assessments or interfere with data collection.
Key Trial Info
Start Date :
December 9 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 3 2025
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT05251701
Start Date
December 9 2022
End Date
September 3 2025
Last Update
October 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tucson Neuroscience Research
Tucson, Arizona, United States, 85710